PT Bundamedik Tbk (ISX:BMHS) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 28, 2026)


ISX:BMHS PT Bundamedik Tbk ISX:BMHS
61 GF Score
Price Rp182.00
GF Value Rp304.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

PT Bundamedik Tbk's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

ISX:BMHS vs HCA, THC, DVA: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Bundamedik Tbk Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's Margin of Safety % (DCF FCF Based) falls into.


ISX:BMHS
61GF Score
PT Bundamedik Tbk ISX:BMHS
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp182.00 is trading 40.2% below its estimated GF Value™ of Rp304.24. GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.

Key valuation signals for ISX:BMHS:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: Rp304.24 vs. price of Rp182.00 (40.2% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score

Get the complete analysis for ISX:BMHS

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp182.00
Price
Rp304.24
GF Value